Sun et al. treated HepG2 (HCC cells) with the antioxidant isoliquiritigenin and inhibited NRF2 by enhancing keap1 expression in the antioxidant pathway, inducing apoptosis, and inhibiting tumor growth in HCC, thereby enhancing its sensitivity to radiotherapy [44]. Here, KEAP1 is linked to hepatocellular carcinoma.